Skip to content
Search for:
About
Mandate & Strategy
Governance & COI Management
CITF Leadership
Research
About CITF-Funded Research
CITF-Funded Research Studies
Hybrid Immunity
Vaccine Surveillance
General Population & Other
Geographic, priority population, Indigenous & 2SLBGTQ+
Long-term Care & Seniors
Pediatric Studies
Healthcare Workers and Occupational Group Studies
Higher Risk Due to Health Conditions
Long COVID and Variants of Concern
Immune Science & Optimization of Immunological Testing Studies
Studies in the CITF Databank
CITF Research Results
SeroTracker
Published Research Papers
Tools & Information for Researchers
CITF Databank
Seroprevalence in Canada
Events
CITF Events
CITF Scientific Meeting E-Posters
Breakout sessions at the CITF Scientific Meeting
Plenary sessions at CITF Scientific Meeting
Hema-Net Serosurveillance Meeting
Media
Media Releases and CITF Announcements
News Coverage
Resources
CITF Monthly Review
Newsletter Back Issues
CITF & International Research Synthesis
Publications from our Experts
FAQs
Jobs
Contact Us
FR
Search for:
About
Mandate & Strategy
Governance & COI Management
CITF Leadership
Research
About CITF-Funded Research
CITF-Funded Research Studies
Hybrid Immunity
Vaccine Surveillance
General Population & Other
Geographic, priority population, Indigenous & 2SLBGTQ+
Long-term Care & Seniors
Pediatric Studies
Healthcare Workers and Occupational Group Studies
Higher Risk Due to Health Conditions
Long COVID and Variants of Concern
Immune Science & Optimization of Immunological Testing Studies
Studies in the CITF Databank
CITF Research Results
SeroTracker
Published Research Papers
Tools & Information for Researchers
CITF Databank
Seroprevalence in Canada
Events
CITF Events
CITF Scientific Meeting E-Posters
Breakout sessions at the CITF Scientific Meeting
Plenary sessions at CITF Scientific Meeting
Hema-Net Serosurveillance Meeting
Media
Media Releases and CITF Announcements
News Coverage
Resources
CITF Monthly Review
Newsletter Back Issues
CITF & International Research Synthesis
Publications from our Experts
FAQs
Jobs
Contact Us
FR
About
Mandate & Strategy
Governance & COI Management
CITF Leadership
Research
About CITF-Funded Research
CITF-Funded Research Studies
Hybrid Immunity
Vaccine Surveillance
General Population & Other
Geographic, priority population, Indigenous & 2SLBGTQ+
Long-term Care & Seniors
Pediatric Studies
Healthcare Workers and Occupational Group Studies
Higher Risk Due to Health Conditions
Long COVID and Variants of Concern
Immune Science & Optimization of Immunological Testing Studies
Studies in the CITF Databank
CITF Research Results
SeroTracker
Published Research Papers
Tools & Information for Researchers
CITF Databank
Seroprevalence in Canada
Events
CITF Events
CITF Scientific Meeting E-Posters
Breakout sessions at the CITF Scientific Meeting
Plenary sessions at CITF Scientific Meeting
Hema-Net Serosurveillance Meeting
Media
Media Releases and CITF Announcements
News Coverage
Resources
CITF Monthly Review
Newsletter Back Issues
CITF & International Research Synthesis
Publications from our Experts
FAQs
Jobs
Contact Us
FR
Search for:
SURVEY FOR KEY INFORMANTS: UNDERSTANDING OPPORTUNITIES TO ASSESS COVID-19 IMMUNITY IN CANADA
SURVEY FOR KEY INFORMANTS: UNDERSTANDING OPPORTUNITIES TO ASSESS COVID-19 IMMUNITY IN CANADA
Simon Labonne
2020-05-09T15:07:55-04:00
On behalf of co-chairs of the COVID-19 Immunity Task Force, Dr. Catherine Hankins and Dr. David Naylor, we would like to thank you for taking the time to complete this survey. The COVID-19 Immunity Task Force was created and funded with a mission to catalyse, support, and, where appropriate and feasible, harmonize the design and rapid implementation of carefully selected population-based studies that will generate reliable first estimates of SARS-CoV-2 immunity, overall and in priority populations across Canada. The purpose of this survey is to understand at a high level what are the current and planned activities to examine immunity status for COVID-19 under the aegis of government, institutional and research processes in Canada. When responding, please describe your institution/study/program and its current studies/services that are, or may be relevant, to the efforts of the COVID-19 Immunity Task Force. If you have more than one relevant service/study, please complete the survey once per each service/study.
Extension of deadline for survey – Given ongoing interest and evidence that many interested respondents may not have received the survey, we are extending the deadline to Friday, May 29th, 5pm. Thanks to all who have responded and to those who have signaled intent to submit.
Email:
Name:
First
Last
Role in institution or study/service:
Name of Team/Agency Lead:
Email Address for Team/Agency Lead:
Are the activities described below currently ongoing, or planned?
Population recruited:
e.g. general, health care workers, health seeking individuals, blood donors, youth, indigenous, etc.
Purpose of survey/service population:
e.g. Built for health care and service? Built for population surveys? Built for other research? Built for COVID-19?, etc.
Location/distribution of population:
e.g. National, provincial, regional, etc.
Recruitment approach:
e.g. convenience, representative, systematic, etc.
Recruitment strategy:
e.g. at point of service, email, mail, street recruitment, social media, other, etc.
Age range:
Sex of participants:
Gender of participants:
Estimated number of participants available for immunity testing:
Recruitment for immunity testing started?
Yes
No
Are you enrolling any of the following participants:
Please check all that apply (or skip the question if none apply).
Antenatal populations
Healthcare workers
Children
Youth
Are demographic or other surveys completed as part of this study/service?
Yes
No
Are height and weight routinely collected as part of this study/service?
Yes
No
Are biological samples routinely collected as part of this study/service?
Yes
No
If biological samples are collected, which ones?
If biological samples are collected, how are they collected?
If biological samples are collected, how are they stored?
If biological samples are collected, how long are they stored for?
Is there a web link describing your study/service?
Is there anything else you would like the COVID-19 Immunity Task Force to know about the study/service?
Name
This field is for validation purposes and should be left unchanged.
This iframe contains the logic required to handle Ajax powered Gravity Forms.
Page load link
Go to Top